This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2014 Sep 11;371(11):1039-49.

doi: 10.1056/NEJMra1404198.

Pancreatic adenocarcinoma

David P Ryan¹, Theodore S Hong, Nabeel Bardeesy

Affiliations

Affiliation

¹ From the Division of Hematology-Oncology, Department of Medicine (D.P.R., N.B.), and the Department of Radiation Oncology (T.S.H.), Massachusetts General Hospital, Boston.

PMID: 25207767
DOI: 10.1056/NEJMra1404198

Review

Pancreatic adenocarcinoma

David P Ryan et al. N Engl J Med. 2014.

. 2014 Sep 11;371(11):1039-49.

doi: 10.1056/NEJMra1404198.

Authors

David P Ryan¹, Theodore S Hong, Nabeel Bardeesy

Affiliation

¹ From the Division of Hematology-Oncology, Department of Medicine (D.P.R., N.B.), and the Department of Radiation Oncology (T.S.H.), Massachusetts General Hospital, Boston.

PMID: 25207767
DOI: 10.1056/NEJMra1404198

No abstract available

PubMed Disclaimer

Comment in

Pancreatic adenocarcinoma.
Ryan DP, Hong TS, Bardeesy N. Ryan DP, et al. N Engl J Med. 2014 Nov 27;371(22):2140-1. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427123 No abstract available.
Pancreatic adenocarcinoma.
Bükki J. Bükki J. N Engl J Med. 2014 Nov 27;371(22):2139-40. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427124 No abstract available.
Pancreatic adenocarcinoma.
Moyer MT, Gaffney RR. Moyer MT, et al. N Engl J Med. 2014 Nov 27;371(22):2140. doi: 10.1056/NEJMc1412266. N Engl J Med. 2014. PMID: 25427125 No abstract available.

Similar articles

Optimizing methods for the diagnosis of pancreatic cancer.
Brugge WR. Brugge WR. J Clin Gastroenterol. 2007 Nov-Dec;41(10):869-70. doi: 10.1097/MCG.0b013e318146849f. J Clin Gastroenterol. 2007. PMID: 18090153 No abstract available.
Use of predictive markers in oncology: are phase 3 trials always required?
Markman M. Markman M. Oncology. 2011;81(1):1-2. doi: 10.1159/000330729. Epub 2011 Sep 2. Oncology. 2011. PMID: 21894048 No abstract available.
Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis.
Talar-Wojnarowska R, Gasiorowska A, Smolarz B, Romanowicz-Makowska H, Strzelczyk J, Janiak A, Kulig A, Malecka-Panas E. Talar-Wojnarowska R, et al. J Physiol Pharmacol. 2004 Jul;55 Suppl 2:129-38. J Physiol Pharmacol. 2004. PMID: 15608367
Targets, trials, and travails in pancreas cancer.
Izeradjene K, Hingorani SR. Izeradjene K, et al. J Natl Compr Canc Netw. 2007 Nov;5(10):1042-53. doi: 10.6004/jnccn.2007.0087. J Natl Compr Canc Netw. 2007. PMID: 18053428 Review.
[Progress of targeted therapy related to K-ras mutation].
Li ZW, Liu YQ. Li ZW, et al. Zhonghua Bing Li Xue Za Zhi. 2012 Jan;41(1):59-61. Zhonghua Bing Li Xue Za Zhi. 2012. PMID: 22455857 Review. Chinese. No abstract available.

See all similar articles

Cited by

Pancreatic Ductal Adenocarcinoma Arising in Young and Old Patients Displays Similar Molecular Features.
Raffenne J, Martin FA, Nicolle R, Konta M, Blum Y, Torrisani J, Puleo F, Bachet JB, Svrcek M, Bardier-Dupas A, Emile JF, Demetter P, Radman M, Van Laethem JL, Hammel P, Rebours V, Paradis V, Couvelard A, Cros J. Raffenne J, et al. Cancers (Basel). 2021 Mar 11;13(6):1234. doi: 10.3390/cancers13061234. Cancers (Basel). 2021. PMID: 33799792 Free PMC article.
Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2.
Miura K, Kimura K, Amano R, Yamazoe S, Ohira G, Murata A, Nishio K, Hasegawa T, Yashiro M, Nakata B, Ohira M, Hirakawa K. Miura K, et al. BMC Cancer. 2016 Apr 11;16:268. doi: 10.1186/s12885-016-2297-y. BMC Cancer. 2016. PMID: 27067801 Free PMC article.
Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.
Takahashi H, Katsuta E, Yan L, Tokumaru Y, Katz MHG, Takabe K. Takahashi H, et al. Cancers (Basel). 2020 Jul 24;12(8):2033. doi: 10.3390/cancers12082033. Cancers (Basel). 2020. PMID: 32722116 Free PMC article.
Risk factors for acute pancreatitis post percutaneous transhepatic biliary stenting in patients with distal malignant obstruction.
Zhang C, Liu Y, Zhou X, Sun Z, Li Y, Hou R, Han X, Jiao D. Zhang C, et al. Quant Imaging Med Surg. 2024 Sep 1;14(9):6508-6516. doi: 10.21037/qims-24-431. Epub 2024 Aug 7. Quant Imaging Med Surg. 2024. PMID: 39281182 Free PMC article.
PubMedPortable: A Framework for Supporting the Development of Text Mining Applications.
Döring K, Grüning BA, Telukunta KK, Thomas P, Günther S. Döring K, et al. PLoS One. 2016 Oct 5;11(10):e0163794. doi: 10.1371/journal.pone.0163794. eCollection 2016. PLoS One. 2016. PMID: 27706202 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal